Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 1 of the last 1 fiscal years.
-
Busy address KBO
38 other companies have their registered office at the same address; threshold 10.
-
Legal situation KBO
Opening faillissement according to the CBE.
Financials
Financial year 2021
BIOTECH GROWTH BELGIUM from Wavre, company number BE0672929580, closed financial year 2021 with a result of € -336 after tax. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2022.
€ -17,865
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -336
Profit after tax over the fiscal year.
Loss, nothing to pay out
Reserves fell to € -36,415.
Debts at end 2021
€ 2,658
Loans from banks and other lenders, long and short.
€ 103,935
Supplier invoices still open on the last day of the fiscal year.
€ 26,873
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
What happened to BIOTECH GROWTH BELGIUM?
What happened at BIOTECH GROWTH BELGIUM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
BIOTECH GROWTH BELGIUM is active according to the CBE. Legal situation: Opening faillissement.
- New annual accounts for financial year 2021: loss of € 336. filed late Source: NBB ↗
- New establishment in Brussel. KBO
- Start of the company according to the CBE. KBO
A new publication or filing at BIOTECH GROWTH BELGIUM? We notify you, reason included.
Follow BIOTECH GROWTH BELGIUMDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Establishments
Establishment units
Physical locations of this company
Rue Charles Jaumotte 31
1300 Wavre
Louizalaan 149 box 24
1050 Brussel
Active since 1 April 2017
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 38 companies are registered at this address.
All companies at this address →Etablissements ENGLEBERT
€ 7,544 gross margin · 2023
DISI INFORMATIQUE
€ -6,705 gross margin · 2025
Maison de Paris
€ 63,442 gross margin · 2025
IMMORAY
€ -21,929 gross margin · 2025
DE SARDANE INVEST
€ 7,716 gross margin · 2025
+33 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0672.929.580
- VAT number
- BE 0672.929.580
- Registered office
- Rue Charles Jaumotte 31, 1300 Wavre
- Names & denominations
- BIOTECH GROWTH BELGIUM
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Opening faillissement
- Start date
- 22 March 2017
- Peppol
- Not registered